Results 101 to 110 of about 441,310 (305)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown +6 more
wiley +1 more source
Current update on the protective effect of epicatechin in neurodegenerative diseases
EXCLI Journal : Experimental and Clinical Sciences, 2022 Riya Thapa +9 more
doaj +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao +7 more
wiley +1 more source
NAVSTAR: Global positioning system an evolutionary research and development program [PDF]
A description is given of NAVSTAR and the conception validation program for the system.
Parkinson, B. W.
core +1 more source
ALDOA Promotes Glycolysis and NLRP3/GSDMD Pyroptosis to Accelerate ALS Progression
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration. Glycolytic dysregulation is implicated in disease progression, yet the underlying mechanisms remain unclear. This study investigates how Aldolase A (ALDOA) drives ALS progression through glycolysis‐mediated motor neuron pyroptosis.
Kaixin Yan +9 more
wiley +1 more source
Tank Tests of Model 11-G Flying-boat Hull [PDF]
The NACA model 11-G flying-boat hull, a modification of NACA model 11-A was tested over a range of loadings. The planing bottom of model 11-G has a variable-radius flare, or concavity, at the chines in contrast to the straight V planing bottom of model ...
Parkinson, J B
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Considerable efforts have been dedicated to developing effective treatments for post‐stroke executive impairment (PSEI), among which repetitive transcranial magnetic stimulation (rTMS) has shown great potential. This study aimed to investigate the therapeutic effects of high‐frequency rTMS on working memory (WM) and response ...
Mengting Lao +6 more
wiley +1 more source
مجله علوم روانشناختی, 2020 Background: The emergence of chronic diseases such as Parkinson seriously damages the patients’ Life Quality and Psychological Wellbeing besides physical health.
Mina Moghtaderi +4 more
doaj
The objectives were to determine and analyze the annual cycle of sea ice extents in the Arctic Ocean and peripheral seas and bays over the period 1973 to 1986, looking in particular for any long term trends; to examine the relationship between local sea ...
Parkinson, C. L.
core +1 more source